Invesco
IMI

Invesco’s Intermolecular, Inc. IMI Stock Holding History

Invesco’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-626,059
Closed -$3.08M – 4363
2013
Q4 		$3.08M Hold
626,059
– – ﹤0.01% 2362
2013
Q3 		$3.45M Sell
626,059
-4,525
-0.7% -$28.4K ﹤0.01% 2174
2013
Q2 		$4.58M Buy
+630,584
New +$5.37M ﹤0.01% 1899

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco's IMI Position: Q1 2014 in Review

Invesco sold out of Intermolecular, Inc. (IMI) in Q1 2014, closing a stake of 626,059 shares — an estimated $3.08M sold.

Invesco first reported a position in IMI in Q2 2013 and held it in 3 quarters. The position peaked at $4.58M in Q2 2013. 53 funds tracked by Wall St. Rank hold IMI as of Q1 2014.

  • Invesco reported no remaining Intermolecular, Inc. position as of Q1 2014 after selling out during the quarter.
  • Invesco sold 626,059 Intermolecular, Inc. shares in Q1 2014, an estimated $3.08M.
  • Invesco first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 3 quarters.
  • Invesco's Intermolecular, Inc. position peaked at $4.58M in Q2 2013.
  • 53 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q1 2014.

Based on Invesco's 13F filing for Q1 2014, filed 15 May 2014.